Swedish Healthcare Services Stock News

OM:FAG
OM:FAGElectrical

European Small Caps With Insider Buying To Consider

The European market has shown resilience, with the pan-European STOXX Europe 600 Index rising by 1.68% and major stock indexes across Germany, Italy, France, and the UK also experiencing gains. Amidst this positive backdrop, small-cap stocks in Europe are gaining attention as potential opportunities for investors seeking to capitalize on insider buying trends and favorable economic indicators such as improved consumer confidence and robust business activity. Identifying stocks that align with...
OM:PRISMA
OM:PRISMAReal Estate

Prisma Properties (OM:PRISMA) One-Off Gain Prompts Rethink on Recent Profit Quality

Prisma Properties (OM:PRISMA) saw its revenue forecast to climb 15.8% per year, while earnings are expected to grow 18.7% annually. This is well ahead of the Swedish market’s 3.8% revenue growth outlook. Over the past five years, Prisma’s earnings rose at a rate of 7.5% per year, and in the last 12 months up to September 30, 2025, the company posted a notable one-off gain of SEK180.0 million that could influence reported EPS quality. Investors are eyeing the company’s strong growth profile,...
OM:VOLO
OM:VOLOIndustrials

Volati (OM:VOLO) Earnings Surge 27.9%—Profit Growth Challenges Bearish Narratives

Volati (OM:VOLO) is forecast to deliver substantial earnings growth of 32.08% per year, with earnings expected to outpace the Swedish market's 12.6% annual rate over the next three years. Revenue is projected to grow at 5.5% annually, ahead of the Swedish market's 3.8%. The net profit margin has climbed to 3.1% compared to last year’s 2.6%. The stock is currently trading at SEK108, below its estimated fair value of SEK285.42. With recent earnings growth of 27.9% over the past year reversing a...
OM:HUMBLE
OM:HUMBLEPersonal Products

Humble Group (OM:HUMBLE) Margin Miss Raises Questions on Quality of Earnings Expansion

Humble Group (OM:HUMBLE) reported a net profit margin of 0.5%, slipping from 0.9% a year ago, even as its earnings have surged at a brisk 45% annual growth rate over the past five years. The company booked a notable one-off gain of SEK18.0 million in the last twelve months, and now sees forecast annual earnings growth accelerating to 83.1%, with revenue expected to grow 5.8% per year. This is well ahead of the 3.8% pace expected for Sweden’s broader market. Despite these bullish forecasts,...
OM:SIVE
OM:SIVESemiconductor

Sivers Semiconductors (OM:SIVE) Revenue Set to Grow 21% Annually, Losses Narrowing—Earnings Preview

Sivers Semiconductors (OM:SIVE) remains unprofitable, but its revenue is projected to grow at an impressive 21% per year. This pace is well ahead of the Swedish market's 3.8% rate. Over the past five years, the company's losses have narrowed at a rate of 8.1% per year, though forecasts suggest it will remain in the red for at least the next three years. Investors are likely to focus on ongoing revenue growth and shrinking losses as they weigh the prospects for eventual profitability in light...
OM:YUBICO
OM:YUBICOSoftware

Yubico (OM:YUBICO) Valuation in Focus After Dashlane Partnership Sparks Passwordless Security Innovation

Yubico (OM:YUBICO) is drawing fresh attention after teaming up with Dashlane to roll out hardware-backed, passwordless authentication. The new integration uses YubiKey to provide truly passwordless, phishing-resistant logins for Dashlane users. See our latest analysis for Yubico. Despite Yubico’s headline-making partnership with Dashlane, investor sentiment has soured, with the stock experiencing a sharp drop. Its 1-day share price return stands at -26.40%, contributing to a year-to-date...
OM:ORX
OM:ORXPharmaceuticals

Orexo (OM:ORX) Heads Into Earnings With Ongoing Losses and Sector-Low 1.8x Price-To-Sales Ratio

Orexo (OM:ORX) remains unprofitable, with losses increasing at an average rate of 3.7% per year over the past five years. Revenue is forecast to grow by 2.5% annually, trailing behind the broader Swedish market’s 3.9% average growth. While the company’s slower growth and ongoing losses present real challenges for investors, the current Price-To-Sales Ratio of 1.8x stands out as a notable value play within the European pharmaceuticals sector. See our full analysis for Orexo. Next up, we’ll see...
OM:VERT B
OM:VERT BSoftware

Vertiseit (OM:VERT B): Margin Drop to 1.8% Challenges Bullish Growth Narrative

Vertiseit (OM:VERT B) is forecasting robust earnings growth of 44.6% per year, significantly ahead of the Swedish market's expected 12.6% pace. Revenue is projected to climb 6.2% annually, outperforming the broader market’s 3.9% rate. Shares currently trade just below their estimated fair value at SEK69.8. Despite the strong top-line and earnings forecasts, net profit margin has narrowed to 1.8% from 9.3% last year. This highlights recent margin pressure, which will be key for investors...
OM:SEDANA
OM:SEDANAMedical Equipment

Sedana Medical (OM:SEDANA): Persistent Losses Challenge Bullish Revenue Growth Narratives in Latest Earnings

Sedana Medical (OM:SEDANA) continues to operate at a loss, with net losses deepening at a steady rate of 1% per year over the last five years and ongoing forecasts pointing to unprofitability for at least the next three years. Meanwhile, revenue is expected to grow an impressive 26.45% per year, well outpacing the Swedish market average of 3.9% each year. This makes strong sales growth the central reward for investors weighing the company’s persistent challenges in reaching profitability. See...
OM:ALLIGO B
OM:ALLIGO BTrade Distributors

Alligo (OM:ALLIGO B) Margin Slide Challenges Bull Case Despite Strong Growth Forecasts

Alligo (OM:ALLIGO B) reported earnings growth of 9.9% per year over the past five years. Most recently, its net profit margin slid to 2.4% from 4.4% last year, signaling a clear margin contraction. Looking ahead, annual earnings are forecast to jump 37.1%, outpacing the Swedish market average of 12.6%, with revenue also expected to grow 5.1% per year. With shares recently trading at SEK121.8, investors are weighing strong growth forecasts against ongoing pressure on profitability and...
OM:PACT
OM:PACTIT

Proact IT Group (OM:PACT) Margin Decline Reinforces Investor Focus on Dividend Sustainability

Proact IT Group (OM:PACT) posted net profit margins of 3.6% this year, narrowing from 4.8% a year ago. Earnings growth declined over the past year, despite a strong five-year track record of 13.8% average annual earnings growth. Revenue is forecast to grow at 3.6% per year, slightly below the Swedish market average of 3.9%. The company’s earnings are expected to rise by a robust 18.89% per year. Investors are watching the solid longer-term profit momentum and attractive valuation metrics...
OM:MMGR B
OM:MMGR BTrade Distributors

Margin Compression Pressures Momentum Group (OM:MMGR B) Outlook Despite Strong Growth Forecasts

Momentum Group (OM:MMGR B) posted average annual earnings growth of 14.5% over the last five years, but the most recent year saw a decline in earnings. Looking ahead, forecasts suggest annual earnings growth of 13.4%, ahead of the Swedish market’s projected 12.6%. Revenue is expected to rise 8.4% per year, easily outpacing local peers. Margin compression, with net profit margins slipping from 6.7% to 5.9%, remains a watchpoint. Yet the outlook for earnings and revenue expansion gives...
OM:FRACTL
OM:FRACTLTech

Fractal Gaming Group (OM:FRACTL) Earnings Surge 84%, Reinforcing Bullish Narrative on Profit Momentum

Fractal Gaming Group (OM:FRACTL) kept its momentum rolling, with earnings leaping 84% over the past year, far outpacing its five-year annual average of 16.3%. Net profit margin rose to 6.5% from last year’s 4.6%, while shares changed hands at SEK34.3, still beneath the discounted cash flow fair value estimate of SEK42.94. With future earnings expected to grow 24.1% per year and no listed risks, upbeat sentiment is underpinned by robust profit trends, improving margins, and compelling...
OM:NEWA B
OM:NEWA BLuxury

European Stocks That May Be Trading Below Their Estimated Value

As the European market navigates a mixed economic landscape, with the pan-European STOXX Europe 600 Index showing modest gains amid dovish signals from U.S. monetary policy and easing trade tensions, investors are keenly observing potential opportunities in undervalued stocks. In this environment, identifying stocks trading below their estimated value can be crucial for those looking to capitalize on discrepancies between current prices and intrinsic worth, offering potential long-term growth...
OM:PCELL
OM:PCELLElectrical

PowerCell Sweden (OM:PCELL) Premium Valuation Faces Test as Profitability Forecast Reinforces Bull Case

PowerCell Sweden (OM:PCELL) remains unprofitable, but over the past five years has managed to reduce its annual losses by 26.4%. Looking ahead, analysts forecast a sharp swing to profitability within three years, with profit expected to grow at a rapid 91.51% per year and revenue projected to expand by 23.1% per year, notably outpacing the wider Swedish market. With both profitability and revenue on an upward trajectory, investors are weighing these high growth expectations against a share...
OM:LEA
OM:LEABanks

Lea Bank (OM:LEA) Margin Decline Challenges Bullish Growth Narrative Despite Strong Forecasts

Lea Bank (OM:LEA) delivered a 30.2% annual decline in earnings over the past five years, with net profit margins narrowing to 29.6% from last year’s 31.4%. However, consensus sees revenue rising at 15.4% per year, which outpaces the Swedish market’s 3.6%. Earnings growth is also expected to accelerate by 30.75% per year, with the current share price of SEK12.7 trading below an estimated fair value of SEK17.5. Investors are now turning their attention to these robust growth forecasts as the...
OM:ESSITY B
OM:ESSITY BHousehold Products

Essity (OM:ESSITY B) Profit Margin Jumps to 8.6%, Reinforcing Bullish Value Narratives

Essity (OM:ESSITY B) posted an impressive year, with earnings rising 23.2% in the most recent period and a five-year annual earnings growth rate of 7.4%. Net profit margins climbed to 8.6% from last year's 6.9%, reflecting a clear improvement in profitability. With earnings set to grow 4.7% annually, but revenue growth forecast at just 2.8% per year, which is behind the Swedish market’s 3.6% average, investors can see improved profits, moderate expansion ahead, and relative value, as shares...
OM:BILL
OM:BILLPackaging

Top European Dividend Stocks For October 2025

As the European market navigates a mixed landscape, with the pan-European STOXX Europe 600 Index inching higher amid dovish signals from the U.S. Federal Reserve and easing U.S.-China trade tensions, investors are keenly eyeing dividend stocks for their potential to provide steady income. In this environment, selecting strong dividend stocks involves looking for companies with solid financial health and consistent payout histories, which can offer stability amidst economic fluctuations.
OM:PDX
OM:PDXEntertainment

Paradox Interactive (OM:PDX) Margin Surge Reinforces Bullish Narratives Despite Premium Valuation

Paradox Interactive (OM:PDX) reported a sharp rise in profitability this period, with a net profit margin of 32.2% versus 13% a year earlier, and annual earnings growth soaring by 106.5%, dwarfing its five-year average of 7.4% per year. Looking forward, earnings are forecast to grow 30.86% per year and revenue is expected to rise at 8.1% annually, both well ahead of the broader Swedish market and industry averages. With profit and revenue growth firmly in view, investors may see these results...
OM:BONEX
OM:BONEXBiotechs

Bonesupport Holding (OM:BONEX) Margin Decline Challenges Bull Case Despite Strong Growth Forecasts

Bonesupport Holding (OM:BONEX) reported high-quality earnings, turning profitable over the last five years and achieving impressive earnings growth of 63% per year during that period. Net profit margins for the most recent period landed at 13.9%, below last year’s 39.3%. Earnings are projected to accelerate by 58.25% per year going forward, outpacing not just the Swedish market but also revenue, which is forecast to grow 30.4% annually compared to a local benchmark of 3.6%. Despite robust...
OM:VIMIAN
OM:VIMIANMedical Equipment

3 European Growth Companies Insiders Are Heavily Investing In

As European markets navigate a mixed landscape marked by dovish signals from the U.S. Federal Reserve and fluctuating industrial outputs, investors are increasingly focusing on growth companies with strong insider ownership as potential opportunities. In this context, stocks with high insider investment can be appealing, suggesting confidence from those closest to the company's operations amid broader economic uncertainties.